Yingxin Chen, Lili Mi, Jianfei Shi, Man Zhao, Fei Yin. Aldo-keto reductase family 1 member B10 in solid tumors: lipid metabolic reprogramming, immune remodeling, and targeted therapy. // Biochemical Pharmacology. – 2027. – DOI: 10.1016/j.bcp.2026.118646. – URL: https://doi.org/10.1016/j.bcp.2026.118646
Yingxin Chen, Lili Mi, Jianfei Shi, Man Zhao, & Fei Yin (2027). Aldo-keto reductase family 1 member B10 in solid tumors: lipid metabolic reprogramming, immune remodeling, and targeted therapy. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118646
Yingxin Chen, et al. “Aldo-keto reductase family 1 member B10 in solid tumors: lipid metabolic reprogramming, immune remodeling, and targeted therapy.” Biochemical Pharmacology, 2027. doi:10.1016/j.bcp.2026.118646.
@article{Chen2027,
title = {Aldo-keto reductase family 1 member B10 in solid tumors: lipid metabolic reprogramming, immune remodeling, and targeted therapy},
author = {Chen, Yingxin and Mi, Lili and Shi, Jianfei and Zhao, Man and Yin, Fei},
journal = {Biochemical Pharmacology},
year = {2027},
doi = {10.1016/j.bcp.2026.118646},
url = {https://doi.org/10.1016/j.bcp.2026.118646}
}